Brachytherapy
Volume 7, Issue 4 , Pages 316-319 , October 2008

The use of the MammoSite balloon applicator in re-irradiation of the breast

  • Mark Trombetta

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212. Tel.: +1-412-359-3400; fax: +1-412-359-3981.
    • ,
  • Thomas Julian

      Affiliations

    • Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA
    • ,
  • Moyed Miften

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
    • ,
  • Woodrow McWilliams

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
    • ,
  • Yongbok Kim

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
    • ,
  • David Parda

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA

Received 2 February 2008 ,Accepted 11 June 2008.

References 

  1. Abner AL, Recht A, Eberlein T, et al. Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol. 1993;11:44–48
  2. Salvadori B, Marubini E, Miceli R, et al. Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery. Br J Surg. 1999;86:84–87
  3. Huang E, Bucholz T, Meric F, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology. Cancer. 2002;95:2059–2067
  4. Doyle T, Schultz D, Peters C, et al. Long-term results of local recurrence after breast conservation treatment for invasive breast cancer. Int J Radiat Oncol Biol Phys. 2001;51:74–80
  5. Edmundson GK, Vicini FA, Chen PY, et al. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 2002;52:1132–1139
  6. Tsai PI, Ryan M, Meek K, et al. Accelerated partial breast irradiation using the MammoSite device: early technical experience and short-term clinical follow-up. Am Surg. 2006;72:929–934
  7. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55:289–293
  8. Benitez PR, Streeter O, Vicini F, et al. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Am J Surg. 2006;192:427–433
  9. Jeruss JS, Vicini FA, Beitsch PD, et al. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast. Ann Surg Oncol. 2006;13:967–976
  10. Trombetta M, Julian T, Bhandari T, et al. Breast conservation brachytherapy and interstitial radiation in the management of locally recurrent carcinoma of the breast: The Allegheny General Hospital experience. Brachytherapy. 2008;7:29–36
  11. Petrovich Z, Langholz B, Lam K, et al. Interstitial microwave hyperthermia combined with Iridium-192 radiotherapy for recurrent tumors. Am J Clin Oncol. 1989;12:264–268
  12. Hannoun-Levi JM, Houvenaeghel G, Ellis S, et al. Partial breast irradiation as second conservative treatment for local breast cancer recurrence. Int J Radiat Oncol Biol Phys. 2004;60:1385–1392
  13. Deutsch M. Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation. Int J Radiat Oncol Biol Phys. 2002;53:687–691
  14. Hodgson D, Koh E, Tran T, et al. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin's lymphoma. Cancer. 2007;110:2576–2586
  15. Vicini FA, White J, Arthur D, et al. NSABP B-39/RTOG 0413 protocol, A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I or II breast cancer. Available at: http://www.rtog.org.
  16. Cancer Therapy Evaluation Program . Common terminology criteria for adverse events. Version 3.0, DCTD, NCI, NIH, DHHS; March 31, 2003. Available at: http://ctep.cancer.govAug 9, 2006;
  17. Fisher B, Bauer M, Margolese R, et al. Five year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312:665–673
  18. Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981;305:6–11

PII: S1538-4721(08)00595-3

doi: 10.1016/j.brachy.2008.06.001

Brachytherapy
Volume 7, Issue 4 , Pages 316-319 , October 2008

Article Tools

* Image Usage & Resolution